$302 Million is the total value of JW Asset Management, LLC's 7 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESTA | ESTABLISHMENT LABS HLDGS INC | $210,711,000 | -5.6% | 3,117,485 | 0.0% | 69.82% | +3.7% | |
| AMZN | AMAZON COM INC | $80,514,000 | +1.5% | 24,147 | 0.0% | 26.68% | +11.5% | |
| HZNP | HORIZON THERAPEUTICS PUB L | $5,461,000 | -1.6% | 50,673 | 0.0% | 1.81% | +8.1% | |
| MSOS | Buy | ADVISORSHARES TRpure us cannabis | $3,286,000 | +266.3% | 128,410 | +352.0% | 1.09% | +301.8% |
| MSAC | MEDICUS SCIENCES ACQUISITION | $969,000 | -0.6% | 100,000 | 0.0% | 0.32% | +9.2% | |
| HMCOU | HUMANCO ACQUISITION CORPunit 12/08/2023 | $861,000 | -1.0% | 85,000 | 0.0% | 0.28% | +8.8% | |
| MSACW | Buy | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $8,000 | 0.0% | 11,110 | +0.1% | 0.00% | +50.0% |
| HYFM | Exit | HYDROFARM HLDGS GROUP INC | $0 | – | -25,000 | -100.0% | -0.28% | – |
| GRWG | Exit | GROWGENERATION CORP | $0 | – | -805,000 | -100.0% | -5.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
| 4 | 2023-12-19 |
| 4 | 2023-12-12 |
| 4 | 2023-12-07 |
| 4 | 2023-12-06 |
| 4 | 2023-11-21 |
| 4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.